• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

omeros

  1. Omeros

    Whats up with this company? I rec'd a call from a recruiter that they were all hot to trot getting someone to Dallas for an interview. She said that they were looking for ophtho experience but when it came down to it they did not pay for any experience. I hope for those that did get an...